NO973363D0 - Neuraminsyrederivater, deres fremstilling og medisinske bruk - Google Patents

Neuraminsyrederivater, deres fremstilling og medisinske bruk

Info

Publication number
NO973363D0
NO973363D0 NO973363A NO973363A NO973363D0 NO 973363 D0 NO973363 D0 NO 973363D0 NO 973363 A NO973363 A NO 973363A NO 973363 A NO973363 A NO 973363A NO 973363 D0 NO973363 D0 NO 973363D0
Authority
NO
Norway
Prior art keywords
preparation
acid derivatives
formula
neuraminic acid
medical uses
Prior art date
Application number
NO973363A
Other languages
English (en)
Other versions
NO973363L (no
NO317704B1 (no
Inventor
Takeshi Honda
Yoshiyuki Kobayashi
Takeshi Masuda
Makoto Yamashita
Arai Masami
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO973363D0 publication Critical patent/NO973363D0/no
Publication of NO973363L publication Critical patent/NO973363L/no
Publication of NO317704B1 publication Critical patent/NO317704B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19973363A 1996-07-22 1997-07-21 Nye neuraminsyrederivater, anvendelse av disse til fremstilling av medikamenter for behandling eller forhindring av infeksjon i et pattedyt forarsaket av et sialidasebaerende virus og farmasoytiske preparater omfattende disse neuraminsyrederivatene. NO317704B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19186296 1996-07-22
JP8688897 1997-04-04

Publications (3)

Publication Number Publication Date
NO973363D0 true NO973363D0 (no) 1997-07-21
NO973363L NO973363L (no) 1998-01-23
NO317704B1 NO317704B1 (no) 2004-12-06

Family

ID=26427962

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19973363A NO317704B1 (no) 1996-07-22 1997-07-21 Nye neuraminsyrederivater, anvendelse av disse til fremstilling av medikamenter for behandling eller forhindring av infeksjon i et pattedyt forarsaket av et sialidasebaerende virus og farmasoytiske preparater omfattende disse neuraminsyrederivatene.

Country Status (19)

Country Link
EP (1) EP0823428B1 (no)
KR (1) KR100506578B1 (no)
CN (1) CN1127494C (no)
AT (1) ATE211468T1 (no)
AU (1) AU700926B2 (no)
CA (1) CA2210492C (no)
CZ (1) CZ291960B6 (no)
DE (1) DE69709795T2 (no)
DK (1) DK0823428T3 (no)
ES (1) ES2167682T3 (no)
HU (1) HU223494B1 (no)
ID (1) ID17474A (no)
IL (1) IL121305A (no)
MX (1) MX9705559A (no)
NO (1) NO317704B1 (no)
NZ (1) NZ328353A (no)
PT (1) PT823428E (no)
RU (1) RU2124509C1 (no)
TW (1) TW418200B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114843564A (zh) * 2022-03-28 2022-08-02 电子科技大学 一种阴阳离子共掺杂的固体氧化物电池氧电极材料及其制备方法

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
SE9904289D0 (sv) * 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections
TWI291462B (en) 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
FR2809104B1 (fr) * 2000-05-19 2002-08-02 Univ Paris Curie Procede de traitement de matiere vegetale, compositions comportant des derives du type n-acylglucosamine, utilisation de ces composes en tant qu'agents bio- protecteurs, et matiere vegetale traitee.
AU2001256759A1 (en) * 2000-05-19 2001-11-26 Sankyo Company Limited Sialic acid derivatives
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2002076980A1 (en) * 2001-03-27 2002-10-03 Sankyo Company, Limited Sialic acid derivatives
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
JP5286251B2 (ja) * 2007-03-07 2013-09-11 第一三共株式会社 インフルエンザ治療剤
TWI460182B (zh) * 2007-04-11 2014-11-11 Daiichi Sankyo Co Ltd 原酸酯之製造方法
KR100930963B1 (ko) * 2008-02-26 2009-12-11 한국기계연구원 적층형 압전파이로트 밸브를 이용한 공조기용 팽창밸브
EP2476675A1 (en) * 2008-11-28 2012-07-18 Cipla Limited Process for preparing zanamivir and intermediates for use in the process
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
CA2762022A1 (en) 2009-05-15 2010-11-18 Redx Pharma Limited Redox drug derivatives
CN102532080A (zh) * 2010-12-29 2012-07-04 中国科学院上海药物研究所 新型唾液酸衍生物及其制备方法,包含该衍生物的药物组合物,以及其用途
ES2640001T3 (es) * 2011-12-16 2017-10-31 Daiichi Sankyo Company, Limited Procedimiento de producción de un derivado del ácido neuramínico
CN104418876B (zh) * 2013-09-09 2019-05-17 中国科学院上海有机化学研究所 扎那米韦和拉那米韦的中间体及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ288492B6 (en) * 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114843564A (zh) * 2022-03-28 2022-08-02 电子科技大学 一种阴阳离子共掺杂的固体氧化物电池氧电极材料及其制备方法
CN114843564B (zh) * 2022-03-28 2023-08-25 电子科技大学 一种阴阳离子共掺杂的固体氧化物电池氧电极材料及其制备方法

Also Published As

Publication number Publication date
HU223494B1 (hu) 2004-08-30
HUP9701270A2 (hu) 1999-09-28
AU2866297A (en) 1998-07-02
TW418200B (en) 2001-01-11
ID17474A (id) 1998-01-08
CZ291960B6 (cs) 2003-06-18
KR980009253A (ko) 1998-04-30
PT823428E (pt) 2002-04-29
AU700926B2 (en) 1999-01-14
NO973363L (no) 1998-01-23
ATE211468T1 (de) 2002-01-15
RU2124509C1 (ru) 1999-01-10
DK0823428T3 (da) 2002-02-18
HU9701270D0 (en) 1997-09-29
CN1127494C (zh) 2003-11-12
NZ328353A (en) 1998-03-25
KR100506578B1 (ko) 2005-12-26
HUP9701270A3 (en) 2002-08-28
CA2210492C (en) 2002-10-29
IL121305A0 (en) 1998-01-04
IL121305A (en) 2003-01-12
DE69709795T2 (de) 2002-09-26
ES2167682T3 (es) 2002-05-16
EP0823428A2 (en) 1998-02-11
NO317704B1 (no) 2004-12-06
EP0823428A3 (en) 1998-02-25
HK1007879A1 (en) 1999-04-30
CN1172807A (zh) 1998-02-11
MX9705559A (es) 1998-05-31
EP0823428B1 (en) 2002-01-02
CZ231697A3 (cs) 1998-02-18
CA2210492A1 (en) 1998-01-22
DE69709795D1 (de) 2002-02-28

Similar Documents

Publication Publication Date Title
DK0823428T3 (da) Neuraminsyrederivater, deres fremstilling og deres medicinske anvendelse
US6046228A (en) Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
BR0211900A (pt) Método para inibição do desenvolvimento de vìrus e/ou virucida, análogos de nucleotìdeo de pirazina e de nucleosìdeo de pirazina, precursor do inibidor da polimerase de rna, inibidor da polimerase de rna, método para tratar pacientes infectados por vìrus, e, usos de um análogo de nucleotìdeo de pirazina ou um sal deste e de um análogo de nucleosìdeo de pirazina ou um sal deste
DK436081A (da) Substituerede acyl-derivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyrer og farmaceutisk acceptable salte deraf fremgangsmaade til deres fremstilling og deres anvendelse
NO302574B1 (no) Indolkarbazolimider og deres anvendelse
HUP0202593A2 (hu) Reverz transzkriptáz inhibitor hatású benzofenonok és ilyen vegyületeket tartalmazó gyógyászati készítmények
KR920700217A (ko) 항 바이러스성 화합물
BR9812364A (pt) Composto, uso do mesmo, composição farmacêutica, derivado de amida, e, processo para a preparação de um derivado de amida ou de um sal farmaceuticamente aceitável ou éster clivável in vivo deste
BR0004786A (pt) Compostos farmaceuticamente ativos
ATE134644T1 (de) Weitere antivirale pyrimidin-nukleosiden
BR9815166A (pt) "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral"
ES2036562T3 (es) Un procedimiento para produccion de un derivado de pirrolidinamida.
DK0915894T3 (da) Nukleotidanaloger
DK132188A (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
DK527984D0 (da) 11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika
HUP9903632A2 (hu) Neuraminsav vegyületek, azokat tartalmazó gyógyszerkészítmények és eljárás e készítmények előállítására
DK0911026T3 (da) Creatinderivater for astma
PT97407A (pt) Processo para a preparacao de (r)-9-{2-(fosfono-metoxi)-propil}-guanina
KR101045985B1 (ko) 아릴 디케토산(adk) 유도체를 유효성분으로 포함하는 사스 코로나 바이러스 저해용 조성물
DK0570245T3 (da) Octahydronaphthalenoximderivater til inbibering af kolesterolbiosyntese, deres fremstilling og anvendelse
NO861923L (no) Nye isoksazolderivater, fremgangsmaate til deres fremstilling, og farmasoeytiske preparater inneholdende dem.
DK1451184T3 (da) Dimere forbindelser og deres anvendelse som antivirale midler
DK0638587T3 (da) Salmyciner, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
SE8505534L (sv) Kemiska foreningar
ATE106727T1 (de) Verwendung eines benzo(b>thiophen-2- carboximidamid-derivates gegen herzinsuffizienz.

Legal Events

Date Code Title Description
MK1K Patent expired